Transmissible spongiform encephalopathies (TSEs or prion disease) are fatal neurodegenerative diseases such as scrapie, Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy and chronic wasting disease (CWD). Our project is aimed at understanding and blocking the conversion of normal PrP (PrP-sen) to PrP-res, the abnormal form of prion protein (PrP) that appears to underlie TSE transmission and pathogenesis. We have employed a wide variety of cell biological, biochemical, biophysical and in vivo experimental approaches. Over the last year we have 1) developed a high throughput scrapie-infected neuroblastoma cell based screen for inhibitors of PrP-res formation, 2) screened >2000 compounds (natural products or drugs approved for other purposes) and identified ~258 new inhibitors, 17 of which are highly potent against 2 different scrapie strains, 3) begun testing these and other inhibitors for prophylactic and therapeutic activities against scrapie in animals, 4) determined that several inhibitors of PrP-res formation can induce conformational changes, aggregation and fibril formation in recombinant PrP-sen, 5) developed a new type of scrapie-infected neuronal cell line (SN56), 6) obtained initial evidence that laminin binding to normal PrP impedes its conversion to PrP-res, 7) identified a strain-specific and metal-ion dependent folding domain of PrP-res, 8) isolated the minimal oligomeric units of PrP-res between 100-300 kD that retain the protease-resistant and conversion-inducing properties of PrP-res and 8) transmitted and adapted chronic wasting disease from deer and elk to hamsters and transgenic mice expressing hamster PrP-sen.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000580-14
Application #
6809275
Study Section
(LPVD)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Caughey, Byron; Baron, Gerald S (2008) Are cheetahs on the run from prion-like amyloidosis? Proc Natl Acad Sci U S A 105:7113-4
Sim, Valerie L; Caughey, Byron (2008) Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol Aging :
Atarashi, Ryuichiro; Wilham, Jason M; Christensen, Leah et al. (2008) Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5:211-2
Liberski, Pawel P; Brown, David R; Sikorska, Beata et al. (2008) Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies). Folia Neuropathol 46:1-25
Caughey, Winslow S; Priola, Suzette A; Kocisko, David A et al. (2007) Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity. Antimicrob Agents Chemother 51:3887-94
Lee, Kil Sun; Caughey, Byron (2007) A simplified recipe for prions. Proc Natl Acad Sci U S A 104:9551-2
Kocisko, David A; Bertholet, Nadine; Moore, Roger A et al. (2007) Identification of prion inhibitors by a fluorescence-polarization-based competitive binding assay. Anal Biochem 363:154-6
Lee, Kil S; Raymond, Lynne D; Schoen, Brianna et al. (2007) Hemin interactions and alterations of the subcellular localization of prion protein. J Biol Chem 282:36525-33
Raymond, Gregory J; Raymond, Lynne D; Meade-White, Kimberly D et al. (2007) Transmission and adaptation of chronic wasting disease to hamsters and transgenic mice: evidence for strains. J Virol 81:4305-14
Atarashi, Ryuichiro; Moore, Roger A; Sim, Valerie L et al. (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4:645-50

Showing the most recent 10 out of 63 publications